N-Nitroso Methyl Flecainide Impurity
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Flecainide is used to prevent and treat abnormally rapid heart rates, including conditions such as paroxysmal supraventricular tachycardia (PSVTs), Wolff-Parkinson-White syndrome, atrioventricular nodal re-entrant tachycardia (AVNRT), AV re-entrant tachycardia (AVRT), and atrial fibrillation/atrial flutter in patients.N-Nitroso Methyl Flecainide Impurity is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Methyl Flecainide Impurity CAS NO:NA chemically represented as N-((4-Methyl-1-nitrosopiperidin-2-yl)methyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide.Synchemia is the leading manufacturing and exporter of N-Nitroso Methyl Flecainide Impurity . We supply N-Nitroso Methyl Flecainide Impurity with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014566 |
| CAS No | 364745-13-1 |
| Mol.F. | C8H4N2O3 |
| Mol.Wt. | 176.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014567 |
| CAS No | NA |
| Mol.F. | C19H17ClN4O6S |
| Mol.Wt. | 464.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014568 |
| CAS No | NA |
| Mol.F. | C49H52F2N10O8 |
| Mol.Wt. | 947.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014569 |
| CAS No | NA |
| Mol.F. | C7H7N5O3 |
| Mol.Wt. | 209.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014570 |
| CAS No | NA |
| Mol.F. | C49H53F2N9O7 |
| Mol.Wt. | 918.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014571 |
| CAS No | NA |
| Mol.F. | C16H18N2O |
| Mol.Wt. | 254.3 |
| INV STATUS | In Stock |
| CAT No | SRC-N014572 |
| CAS No | NA |
| Mol.F. | C16H19N5O4S |
| Mol.Wt. | 377.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014573 |
| CAS No | NA |
| Mol.F. | C13H20N2O4 |
| Mol.Wt. | 268.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014574 |
| CAS No | NA |
| Mol.F. | C20H24N8O7 |
| Mol.Wt. | 488.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014575 |
| CAS No | NA |
| Mol.F. | C20H23N9O8 |
| Mol.Wt. | 517.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014576 |
| CAS No | NA |
| Mol.F. | C20H24N8O7 |
| Mol.Wt. | 488.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014577 |
| CAS No | NA |
| Mol.F. | C20H20N8O8 |
| Mol.Wt. | 500.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014578 |
| CAS No | NA |
| Mol.F. | C20H19N9O9 |
| Mol.Wt. | 529.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014579 |
| CAS No | NA |
| Mol.F. | C20H22N8O8 |
| Mol.Wt. | 502.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014580 |
| CAS No | NA |
| Mol.F. | C11H11Cl2N3O2 |
| Mol.Wt. | 288.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014581 |
| CAS No | 2518136-84-8 |
| Mol.F. | C11H13ClN2O |
| Mol.Wt. | 224.7 g/mol |
| INV STATUS | UNDER SYNTHESIS |